TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32672489

Group type: EXPERIMENTAL
Intervention: Imatinib (IM) and hydroxyurea (HU) combination therapy
Number of subjects: 137

Group type: COMPARATOR
Intervention: Imatinib (IM) monotherapy
Number of subjects: 137
Study: 36291230

Group type: EXPERIMENTAL
Intervention: 20 Hz t‐VNS in the auricular concha area
Number of subjects: 30

Group type: COMPARATOR
Intervention: Periauricular area (control group)
Number of subjects: 30
Study: 36435838

Group type: EXPERIMENTAL
Intervention: Tailored lifestyle and intensively supplemented with oral nutrition support (Group SS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard medical care (Group NN)
Number of subjects: 0
Study: 33952426

Group type: EXPERIMENTAL
Intervention: Biliopancreatic limb length of 200 cm
Number of subjects: 210

Group type: COMPARATOR
Intervention: Biliopancreatic limb length of 50 cm
Number of subjects: 210
Study: 33237906

Group type: EXPERIMENTAL
Intervention: Outdoor recreational activity experiences
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 36396298

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided pudendal nerve block
Number of subjects: 155

Group type: COMPARATOR
Intervention: Ultrasound-guided dorsal penile nerve block
Number of subjects: 155
Study: 33307998

Group type: EXPERIMENTAL
Intervention: peginterferon beta-1a
Number of subjects: 0

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: sNfL levels
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: active MS
Number of subjects: 0
Study: 33187167

Group type: EXPERIMENTAL
Intervention: Upper cervical translatoric mobilization
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Inhibitory suboccipital technique
Number of subjects: 78

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 78
Study: 35072578

Group type: EXPERIMENTAL
Intervention: Standard Cognitive Behavioral Therapy (CBT)
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Adapted Cognitive Behavioral Therapy (CBT)
Number of subjects: 148
Study: 33588644

Group type: EXPERIMENTAL
Intervention: Copenhagen Adduction Exercise (CAE)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Nordic Hamstring Exercise (NHE)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Copenhagen Adduction Exercise + Nordic Hamstring Exercise (CAE + NHE)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 200
Study: 34244463

Group type: EXPERIMENTAL
Intervention: Child perspective videos
Number of subjects: 106

Group type: COMPARATOR
Intervention: Adult perspective videos
Number of subjects: 106
Study: 33428233

Group type: EXPERIMENTAL
Intervention: Inhaled nitric oxide (iNO) at 40 ppm
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo (normoxic gas)
Number of subjects: 15
Study: 32507560

Group type: EXPERIMENTAL
Intervention: DetectNet
Number of subjects: 550

Group type: EXPERIMENTAL
Intervention: AlexNet
Number of subjects: 550

Group type: EXPERIMENTAL
Intervention: VGG-16
Number of subjects: 550

Group type: COMPARATOR
Intervention: Control group (patients without ISTs)
Number of subjects: 550
Study: 36121664

Group type: EXPERIMENTAL
Intervention: Immediate screening at age 45
Number of subjects: 46495

Group type: COMPARATOR
Intervention: Deferred screening at age 50
Number of subjects: 46495

Group type: EXPERIMENTAL
Intervention: High-risk group (both arms)
Number of subjects: 46495

Group type: EXPERIMENTAL
Intervention: Self-initiated PSA tests
Number of subjects: 46495

Group type: EXPERIMENTAL
Intervention: Men with a history of digital rectal examination or PSA testing
Number of subjects: 46495
Study: 34529714

Group type: EXPERIMENTAL
Intervention: Multi-faceted intervention engaging traditional and religious leaders
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Subsequent scale-up of the intervention
Number of subjects: 0
Study: 32297776

Group type: EXPERIMENTAL
Intervention: Coaching intervention (six-session positive psychology-based)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Waitlisted control group
Number of subjects: 59
Study: 36146909

Group type: EXPERIMENTAL
Intervention: Educational intervention targeting parents (informational handouts and videos about health effects of juice and SSBs)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Educational intervention targeting parents
Number of subjects: 144
Study: 34718462

Group type: EXPERIMENTAL
Intervention: POC EID (on-site testing with the Alere q HIV-1/2 Detect)
Number of subjects: 4000

Group type: COMPARATOR
Intervention: SOC EID (enhanced standard of care, off-site testing at a public laboratory)
Number of subjects: 4000
Study: 32730026

Group type: EXPERIMENTAL
Intervention: Self-administered intervention
Number of subjects: 297

Group type: EXPERIMENTAL
Intervention: Self-administered plus telephone intervention
Number of subjects: 297

Group type: COMPARATOR
Intervention: Active control condition
Number of subjects: 297
Study: 35928565

Group type: EXPERIMENTAL
Intervention: Mixed Circuit Training (MCT)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Control (CTL)
Number of subjects: 7
Study: 32391627

Group type: EXPERIMENTAL
Intervention: Multi-layered silicone foam dressings
Number of subjects: 422

Group type: COMPARATOR
Intervention: Standard prevention (Control)
Number of subjects: 422
Study: 35763112

Group type: EXPERIMENTAL
Intervention: Dance classes for 22 weeks
Number of subjects: 49
Study: 34412668

Group type: EXPERIMENTAL
Intervention: Aerobic exercise (AE) for 40 min on a cycle ergometer at 60% of HR reserve
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Resistance exercise (RE) for 40 min at 60% 1-RM
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Combined exercise (CE) for 20 min RE + 20 min AE
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: α1-adrenergic blocker (doxazosin 0.05 mg/kg)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 32993607

Group type: EXPERIMENTAL
Intervention: Healthy Workplace Participatory Program (HWPP)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Lagged intervention (no immediate HWPP intervention)
Number of subjects: 6
Study: 35791670

Group type: EXPERIMENTAL
Intervention: ABO-compatible cryoprecipitate
Number of subjects: 363

Group type: COMPARATOR
Intervention: ABO-incompatible cryoprecipitate
Number of subjects: 363
Study: 34855613

Group type: EXPERIMENTAL
Intervention: Social media recruitment (paid advertisements on Facebook, Instagram, and Grindr)
Number of subjects: 414

Group type: EXPERIMENTAL
Intervention: Instagram recruitment
Number of subjects: 414

Group type: EXPERIMENTAL
Intervention: Grindr recruitment
Number of subjects: 414

Group type: COMPARATOR
Intervention: Venue-based recruitment (clubs, bars, community centers, AIDS service organizations)
Number of subjects: 414
Study: 35862109

Group type: EXPERIMENTAL
Intervention: Coronary artery bypass grafting (CABG)
Number of subjects: 1656

Group type: COMPARATOR
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 1656
Study: 33588490

Group type: EXPERIMENTAL
Intervention: Navigated screw fixation
Number of subjects: 36

Group type: COMPARATOR
Intervention: Conventional screw fixation
Number of subjects: 36
Study: 34775476

Group type: EXPERIMENTAL
Intervention: Early feeding progression (feeding day 2)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Delayed feeding progression (feeding day 5)
Number of subjects: 51
Study: 33769117

Group type: EXPERIMENTAL
Intervention: Fingolimod (0.5–1.25 mg/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: IFNβ‐1a–fingolimod switch group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Continuous fingolimod
Number of subjects: 0
Study: 34344316

Group type: EXPERIMENTAL
Intervention: Self-care educational intervention (intensive four-day training and one-day follow-up sessions every four months, with illustrated educational leaflets)
Number of subjects: 186

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 186
Study: 32075015

Group type: EXPERIMENTAL
Intervention: Dark Chocolate (DC)
Number of subjects: 98

Group type: COMPARATOR
Intervention: White Chocolate (WC)
Number of subjects: 98
Study: 35276329

Group type: EXPERIMENTAL
Intervention: 130 mg ustekinumab
Number of subjects: 961

Group type: EXPERIMENTAL
Intervention: approximately 6 mg/kg ustekinumab
Number of subjects: 961

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 961

Group type: EXPERIMENTAL
Intervention: ustekinumab groups
Number of subjects: 961
Study: 32107609

Group type: EXPERIMENTAL
Intervention: Ramucirumab (8 mg/kg intravenously every 2 weeks)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study: 32686617

Group type: EXPERIMENTAL
Intervention: elotuzumab
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ixazomib
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: daratumumab
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: panobinostat
Number of subjects: 0
Study: 36428083

Group type: EXPERIMENTAL
Intervention: Supervised high‐intensity exercise training programme
Number of subjects: 169

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 169
Study: 34117162

Group type: EXPERIMENTAL
Intervention: modified directly administered ART (mDAART) plus standard of care
Number of subjects: 50

Group type: COMPARATOR
Intervention: standard of care alone
Number of subjects: 50
Study: 33001136

Group type: EXPERIMENTAL
Intervention: Durvalumab with or without Tremelimumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard chemotherapy
Number of subjects: 0
Study: 35627346

Group type: EXPERIMENTAL
Intervention: Robot group A (30% body weight support)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Robot group B (50% body weight support)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Robot group C (70% body weight support)
Number of subjects: 24
Study: 33132112

Group type: EXPERIMENTAL
Intervention: HAVISA health messages in television advertisements for unhealthy foods
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no health messages)
Number of subjects: 100
Study: 32410400

Group type: EXPERIMENTAL
Intervention: Nifedipine alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nifedipine combined with sildenafil citrate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 33958719

Group type: EXPERIMENTAL
Intervention: Bovine milk-based infant formula with 7.2 g MOS/L
Number of subjects: 115

Group type: COMPARATOR
Intervention: Control group (bovine milk-based, alpha-lactalbumin, and sn-2 palmitate enriched infant formula)
Number of subjects: 115
Study: 34188460

Group type: EXPERIMENTAL
Intervention: Rehabilitation nursing program (30 minutes per session, two sessions per day for seven consecutive days)
Number of subjects: 224

Group type: COMPARATOR
Intervention: Therapist-led rehabilitation (same timing and frequency as experimental group)
Number of subjects: 224

Group type: EXPERIMENTAL
Intervention: Rehabilitation nursing program
Number of subjects: 224

Group type: COMPARATOR
Intervention: Therapist-led rehabilitation
Number of subjects: 224

Group type: EXPERIMENTAL
Intervention: Rehabilitation nursing program and therapist-led rehabilitation
Number of subjects: 224
Study: 32273276

Group type: EXPERIMENTAL
Intervention: Cy/GVAX followed by CRS-207 with nivolumab (Arm A)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Cy/GVAX followed by CRS-207 without nivolumab (Arm B)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Cy/GVAX followed by CRS-207 (Arm A)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Cy/GVAX followed by CRS-207 (Arm B)
Number of subjects: 93
Study: 34984660

Group type: EXPERIMENTAL
Intervention: Faith-based group education and motivational interviewing intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Delayed group (control)
Number of subjects: 0
Study: 34113435

Group type: COMPARATOR
Intervention: Modular intervention to improve paternal involvement in infant and young child feeding (IYCF); implemented through monthly visits for six months.
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned); participants receive standard care without the modular intervention.
Number of subjects: 120
Study: 32423247

Group type: EXPERIMENTAL
Intervention: Intranasal steroids (Nasacort)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo (Ayr saline spray)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Surgery
Number of subjects: 42
Study: 36205265

Group type: EXPERIMENTAL
Intervention: SpHb measurement
Number of subjects: 120
Study: 34510448

Group type: EXPERIMENTAL
Intervention: Vertical parasagittal hemispherotomy
Number of subjects: 672

Group type: COMPARATOR
Intervention: Lateral peri-insular/peri-Sylvian or trans-Sylvian hemispherotomy
Number of subjects: 672

Group type: COMPARATOR
Intervention: Lateral hemispherotomy technique
Number of subjects: 672
Study: 32461526

Group type: EXPERIMENTAL
Intervention: Low-carbohydrate high-monounsaturated fatty acid (LC/HM) formula
Number of subjects: 10

Group type: COMPARATOR
Intervention: Standard control formula
Number of subjects: 10
Study: 34690272

Group type: EXPERIMENTAL
Intervention: SMILE
Number of subjects: 74

Group type: COMPARATOR
Intervention: PRK
Number of subjects: 74
Study: 32739355

Group type: EXPERIMENTAL
Intervention: Partial breast irradiation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Endocrine therapy
Number of subjects: 0
Study: 35505251

Group type: EXPERIMENTAL
Intervention: Anti-epileptic drugs (AEDs)
Number of subjects: 9261

Group type: EXPERIMENTAL
Intervention: HDACi anti-epileptic drugs (AEDs)
Number of subjects: 9261

Group type: COMPARATOR
Intervention: Other anti-epileptic drugs (AEDs)
Number of subjects: 9261
Study: 32139486

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 152

Group type: COMPARATOR
Intervention: Placebo acupuncture
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Both groups (Acupuncture and Placebo acupuncture)
Number of subjects: 152
Study: 36153033

Group type: EXPERIMENTAL
Intervention: Screening only
Number of subjects: 880

Group type: EXPERIMENTAL
Intervention: Screening and provision of resource sheet(s)
Number of subjects: 880

Group type: EXPERIMENTAL
Intervention: Screening and provision of resource sheet(s) plus social work assistance
Number of subjects: 880
Study: 33008451

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (0.8 μg/kg administered for 10 min before anesthesia)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Normal saline (equal volume)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 94
Study: 36271441

Group type: EXPERIMENTAL
Intervention: Remote consenting used by 30/37 sites for 54/156 recruits
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Remote site initiation visits (SIVs) conducted remotely
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Remote data monitoring used by 5 sites
Number of subjects: 156
Study: 33720960

Group type: EXPERIMENTAL
Intervention: Regimen D (injection gentamicin once daily for 2 days plus oral amoxicillin twice daily for 7 days)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Regimen B (injection gentamicin once daily plus oral amoxicillin twice daily, both for 7 days)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Regimen C (once daily injection gentamicin plus injection procaine penicillin for 2 days, thereafter oral amoxicillin twice daily for 5 days)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Regimen E (oral amoxicillin twice daily for 7 days)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Reference regimen A (injection gentamicin plus injection procaine penicillin both once daily for 7 days)
Number of subjects: 0
Study: 32171429

Group type: EXPERIMENTAL
Intervention: 18F-FDG PET-based target group
Number of subjects: 205

Group type: COMPARATOR
Intervention: Conventional target group
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 205
Study: 35179608

Group type: EXPERIMENTAL
Intervention: Dry needling
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Manual trigger point pressure release
Number of subjects: 50

Group type: COMPARATOR
Intervention: Both interventions
Number of subjects: 50
Study: 33846237

Group type: EXPERIMENTAL
Intervention: BPCA-sponsored studies
Number of subjects: 10918
Study: 32725731

Group type: EXPERIMENTAL
Intervention: Routine evaluation of gastric aspirates
Number of subjects: 0

Group type: COMPARATOR
Intervention: Selective evaluation of gastric aspirates
Number of subjects: 0
Study: 34676542

Group type: EXPERIMENTAL
Intervention: Fenfluramine 0.7 mg/kg/day
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Fenfluramine 0.2 mg/kg/day
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Fenfluramine 0.4 mg/kg/day
Number of subjects: 206

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 206
Study: 32859616

Group type: EXPERIMENTAL
Intervention: Caloric-restriction diet (goal: 10% weight-loss)
Number of subjects: 438

Group type: EXPERIMENTAL
Intervention: Aerobic-exercise (225 min/week moderate-to-vigorous activity)
Number of subjects: 438

Group type: EXPERIMENTAL
Intervention: Combined diet+exercise
Number of subjects: 438

Group type: COMPARATOR
Intervention: Control
Number of subjects: 438
Study: 35725652

Group type: EXPERIMENTAL
Intervention: MSCs transplantation
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: MSCs transplantation combined with exercise
Number of subjects: 21
Study: 32278340

Group type: EXPERIMENTAL
Intervention: Mechanical debridement with hand and powered instruments and 980-nm diode laser application (test group, N=38)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Mechanical debridement alone (control group, N=35)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Both groups (test and control)
Number of subjects: 73
Study: 32502358

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (standard medication only)
Number of subjects: 32
Study: 33828845

Group type: EXPERIMENTAL
Intervention: EMBRACE intervention
Number of subjects: 1490
Study: 34607469

Group type: EXPERIMENTAL
Intervention: Endovascular treatment
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Outcome adjudication committee assessment
Number of subjects: 500

Group type: COMPARATOR
Intervention: Misclassification by central assessor
Number of subjects: 500
Study: 33849503

Group type: EXPERIMENTAL
Intervention: Music exposure at 70 dB SPL
Number of subjects: 87

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Earplug group
Number of subjects: 87
Study: 35314481

Group type: EXPERIMENTAL
Intervention: Multifaceted intervention including phone surveys, center-specific audit/feedback, educational package, and academic detailing visit
Number of subjects: 5312

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 5312
Study: 33667699

Group type: EXPERIMENTAL
Intervention: active-tDCS (M1-S0, 2 mA, 20 min)
Number of subjects: 58

Group type: COMPARATOR
Intervention: sham-tDCS
Number of subjects: 58
Study: 32809893

Group type: EXPERIMENTAL
Intervention: Baseline legumain levels
Number of subjects: 4883

Group type: EXPERIMENTAL
Intervention: Legumain levels at 1 month
Number of subjects: 4883
Study: 34061572

Group type: EXPERIMENTAL
Intervention: Text messaging behaviors of individuals with chronic aphasia over a 7-day period.
Number of subjects: 20
Study: 34814693

Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) injections at the time of surgery
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no injections)
Number of subjects: 100
Study: 32470244

Group type: EXPERIMENTAL
Intervention: Zirconia crowns
Number of subjects: 50

Group type: COMPARATOR
Intervention: Stainless steel crowns (SSCs)
Number of subjects: 50
Study: 33706543

Group type: EXPERIMENTAL
Intervention: Clinical Pilates
Number of subjects: 46

Group type: COMPARATOR
Intervention: Home exercises
Number of subjects: 46
Study: 33305552

Group type: EXPERIMENTAL
Intervention: Beta-alanine (4.8 g·day-1 for four weeks)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 16
Study: 35104197

Group type: EXPERIMENTAL
Intervention: Nomothetic clinical feedback
Number of subjects: 329

Group type: EXPERIMENTAL
Intervention: Individualized clinical feedback
Number of subjects: 329

Group type: EXPERIMENTAL
Intervention: Combined clinical feedback
Number of subjects: 329

Group type: EXPERIMENTAL
Intervention: Cognitive behavioral participants
Number of subjects: 329
Study: 33819508

Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy (SLIT)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Subcutaneous immunotherapy (SCIT)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Subcutaneous immunotherapy (SCIT) and Sublingual immunotherapy (SLIT)
Number of subjects: 84
Study: 35562815

Group type: EXPERIMENTAL
Intervention: STAR care pathway (assessment clinic at three months and up to six follow-up telephone calls over 12 months)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: STAR care pathway
Number of subjects: 27

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 27
Study: 32268436

Group type: EXPERIMENTAL
Intervention: Early-onset abiraterone acetate plus prednisone (AA+P) therapy
Number of subjects: 159

Group type: COMPARATOR
Intervention: Late-onset abiraterone acetate plus prednisone (AA+P) therapy
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Missed early-onset therapy assignment (MEC)
Number of subjects: 159
Study: 36498825

Group type: EXPERIMENTAL
Intervention: XP-Endo Shaper Sequence (XPS)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Full-sequence Self-Adjusting File (SAF)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Manual K-files (HKF)
Number of subjects: 120
Study: 32321565

Group type: EXPERIMENTAL
Intervention: Four cycles of chemotherapy (CT)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Two cycles of chemotherapy followed by two cycles of durvalumab and subsequent maintenance treatment with durvalumab every 4 weeks
Number of subjects: 200
Study: 32299371

Group type: EXPERIMENTAL
Intervention: Daily weight monitoring
Number of subjects: 396